Apelin suppresses the proliferative effect of estrogen on epithelial (OVCAR-3) ovarian cancer cell lines and insulin-like growth factor 1 (IGF-1) on granulocyte (COV434) ovarian cancer cell lines by the interaction of the apelin receptor with those hormones’ receptors [59]. Here, APLN is linked to ovarian carcinoma.